Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics:  Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

5
(414)
Write Review
More
$ 29.50
Add to Cart
In stock
Description

Full article: A Platform analytical method for intact polysorbates in protein-containing biopharmaceutical products via HPLC-CAD

Therapeutic efficacy of nanoparticles and routes of administration, Biomaterials Research

Structural and biochemical characterization of a novel thermophilic Coh01147 protease

Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy. - Abstract - Europe PMC

Residual Host Cell Protein Promotes Polysorbate 20 Degradation in a Sulfatase Drug Product Leading to Free Fatty Acid Particles - Journal of Pharmaceutical Sciences

Effects of chitosan and Tween 80 addition on the properties of nanofiber mat through the electrospinning

Bisacylphosphane oxides as photo-latent cytotoxic agents and potential photo-latent anticancer drugs

FORMULATING PEPTIDES - Novel Formulations for Non-Invasive Delivery & Stabilization of Peptides

Screening of Polysorbate-80 Composition by High Resolution Mass Spectrometry with Rapid H/D Exchange

Effect of Surfactant Type on Surfactant−Protein Interactions at the Air−Water Interface

WO2019207021A1 - Methods for purification of polypeptides using

View of ANALYSIS OF POLYSORBATE 80 SOLUTION STABILITY UNDER STRESS CONDITIONS TO ENSURE ITS QUALITY AS A BIOPHARMACEUTICAL EXCIPIENT

The degradation of poloxamer 188 in buffered formulation conditions, AAPS Open